log in
Print | Back

Haynes and Boone, LLP

Suzanne A. Trigg

Suzanne A. Trigg

Partner

Haynes and Boone, LLP
Texas, U.S.A.

tel: +1 214 651 5098
Send an Email

Local Time: Fri. 17:50

Profile
With a focus on guiding companies through FDA regulatory issues, supply chain management and strategic growth, Suzie Trigg represents restaurant chains, retailers, franchisors, and consumer products companies in negotiating and documenting transactions and understanding regulatory requirements so that they can make informed choices.

Suzie Trigg is a go-to lawyer for companies tackling supply chain changes, having been lead outside counsel, among others, for:

A 7,500+ store retailer in negotiating supply chain agreements for transactions expected to total $25 billion over five years
Multiple global restaurant chains in updating supplier standards and supply chain agreements and in helping to address potential gaps in food safety
A global food company in restructuring a subsidiary's distribution network, including negotiating multiple termination and release agreements and a series of new agreements
A fresh produce company in developing agreements for use with growers, processors, storage facilities and others in the supply chain
A cosmetics company developing distribution agreements for use in three dozen countries

Suzie also helps companies lawfully market their products by helping them review labels, product claims and their substantiation, and by reviewing online promotional materials. Her experience in this area includes foods, dietary supplements, cosmetics, personal care products, medical devices, jewelry, and decorative items. She frequently provides advice and guidance on strategies to reduce the risk of a demand, class action, or regulatory enforcement related to a product's labeling or promotion.

While much of her work focuses on managing legal risks and forming compliance strategies designed to minimize risk and avoid costly delays or setbacks, Suzie also helps companies quickly, thoroughly, and efficiently address obstacles, such as regulatory enforcement, potential product recalls, and disputes with distributors or other supply chain partners.

Given Suzie's experience, she often assists with mergers and acquisitions, including by leading due diligence of FDA regulated consumer products companies, negotiating ancillary agreements with supply chain partners, and helping address issues critical to deal closure, such as food safety concerns.

Suzie serves on FDLI's Food and Dietary Supplements Committee and previously served on FDLI's Writing Awards Committee. Suzie has completed coursework in food law through Michigan State University's Institute for Food Laws and Regulations and is a member of the Institute of Food Technologists (IFT).

Suzie is actively involved in the ABA Forum on Franchising, regularly contributing to publications and Forum committees, and is a past Vice Chair of the Dallas Bar Association's Franchise and Distribution Law Section.


Education

J.D., University of Texas at Austin School of Law, 2006, with honors, Texas Environmental Law Journal
B.S., Animal Science, Texas A&M University, 2003
Areas of Practice
Professional Career

Significant Accomplishments

Franchise and Product Distribution

Structured international distribution agreements for a cosmetic manufacturer intending to distribute products in over 30 countries and for a medical device manufacturer intending to distribute devices in over 20 countries.

Represented retailer of mobile and technology products in the negotiation of a development arrangement for 1,000 franchised locations in Southeast Asia.

Advised restaurant and hotel franchise systems in exemption-based franchising, development at airports, and development on military bases and Indian reservations.

Drafted and registered franchise disclosure documents for use in the U.S. and other countries.


Strategic Supply Chain Initiatives

Represented franchisor of two brands with over 500 restaurants in the formation of a purchasing cooperative.

Structured and implemented an international buying group for Fortune 500 mobile and technology products provider.

Represented ranch owner in structuring and documenting management relationship for joint venture producing specialty, premium brand of beef.

Represented produce company in drafting and negotiating agreements with growers, including for imported produce.

Advised leading bedding manufacturer on long term strategic supply chain initiative, including the negotiation and implementation of several third party logistics agreements, carrier agreements, first and second tier supply agreements and a variety of related service agreements.


Regulatory Matters

Advised restaurant chains on the use of health claims and allergen declarations and warnings, on food safety and on new regulations affecting their operations, such as menu labeling.

Advised consumer packaged goods companies on product labeling and claims, including the use of "all natural", "organic", "gluten-free" and similar statements.

Advised meat company on the impact of certain animal husbandry practices on product labeling and promotion.

Drafted international good distribution practices manual for restaurant chain addressing food safety, supplier verification and related issues.

Assisted OTC-drug and cosmetic product manufacturer in responding to an FDA Form 483.
Articles

The IP Beacon, April 2018
Haynes and Boone, LLP, April 2018

View the PDF version of the April 2018 IP Beacon. Are Works Generated by AI Subject to IP Protection? When Philip Dick wrote the 1968 novel "Do Androids Dream of Electric Sheep?," the inspiration for the 1982 film "Blade Runner," artificial intelligence was more fiction than science. Fifty years later, theHarvard Business Reviewpredicts that AI will be the single biggest technological development of our era, as transformative as the steam engine or electricity...

Health Law Vitals - A Healthcare Newsletter from Haynes and Boone, March 2018
Haynes and Boone, LLP, March 2018

 More than two and a half years after the U.S. Food and Drug Administration (FDA) announced that it was reevaluating its regulatory framework for homeopathic products, the FDA released its Draft Guidance on Drug Products Labeled as Homeopathic. The Draft Guidance summarizes the FDA’s current enforcement perspective on homeopathic products and provides a list of the FDA’s enforcement priorities.The bills reawakened a debate about the pros and cons of POHs...

FDA Draft Guidance Proposes Risk-Based Regulatory Scheme for Drug Products Labeled as Homeopathic
Haynes and Boone, LLP, March 2018

More than two and a half years after the U.S. Food and Drug Administration (FDA) announced that it was re-evaluating its regulatory framework for homeopathic products, the FDA released its Draft Guidance on Drug Products Labeled as Homeopathic. The Draft Guidance summarizes the FDA’s current enforcement perspective on homeopathic products and provides a list of the FDA’s enforcement priorities...

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | DISCLAIMER |  © World Services Group, 2018